Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

Authors: Gabriel N. Hortobágyi, Salomon M. Stemmer, H.A. Burris, Yoon Sim Yap, Gabe S. Sonke, Shani Paluch–Shimon, M. Campone, Katarína Petráková, Kimberly Blackwell, Eric P. Winer, W Janni, Sunil Verma, PierFranco Conte, Carlos L. Arteaga, David Cameron, S. Mondal, Fei Su, Marshall G. Miller, Mohamed Elmeliegy, Caroline Germa, Joyce O’Shaughnessy - Annals of Oncology 2018 cited by 868